Wednesday
June 4
Tuesday
June 3
Sunday
June 1
Monday
June 2
Saturday
May 31
D01: Tailoring Sleep Medications for
Individual Patients
10:30am – 12:30pm
Chair:
Thomas Roth, PhD
Faculty:
Ruth Benca, MD, PhD; Daniel Buysse, MD;
Andrew Krystal, MD; Kenneth Lichstein, PhD; Mark
Mahowald, MD; and Phyllis Zee, MD, PhD
Psychologist Level of Content:
Intermediate
Objectives:
1. Discuss important pharmacokinetics that define
hypnotic efficacy and safety;
2. Explain clinical implications of individual differences
in demographic variables, nature of insomnia and
comorbid conditions impacting hypnotic use; and
3. Develop clinical guidelines for tailoring different
medications for individual patients.
O04: Evaluating Sleep Disordered Breathing
10:30am – 12:30pm
Psychologist Level of Content:
Intermediate
Objective:
Evaluate new data about assessments in OSA
and obesity/hypoventilation.
S05: Disturbed Sleep as a Suicide Risk
Factor and Novel Treatment Target: An
Opportunity for Prevention
10:30am – 12:30pm
Chair:
Rebecca Bernert, PhD
Faculty:
Vaughn McCall, MD; Michael Perlis, PhD; and
Wilfred Pigeon, PhD
Psychologist Level of Content:
Intermediate
Objectives:
1. Review the evidence base and public health
significance supporting evaluation of disturbed sleep
as a suicide risk factor and warning sign and common
methodological problems that challenge this area of
research;
2. Describe the scientific and clinical rationale regarding
treatment development of interventions targeting
sleep to reduce risk for suicide, as well as inherent
methodological challenges; and
3. Discuss behavioral research findings in the
development, conduct and feasibility testing of
sleep-focused treatments for suicide prevention and
preliminary indications of response.
S06: Neurodegeneration: Advances in
Translational Neuroscience
10:30am – 12:30pm
Chair:
Clifford Saper, MD, PhD
Faculty:
Christian Baumann, MD; David Holtzman, MD;
Miranda Lim, MD, PhD; and Jacques Montplaisir, MD, PhD
Psychologist Level of Content:
Advanced
Objectives:
1. Review new data on the neuroscience of
neurodegenerative disease and brain injury;
2. Discuss the association between genetic and
sleep patterns, and development of specific
neurodegenerative disorders; and
3. Analyze interventional strategies and their
mechanisms.
S07: Circadian Rhythms, Sleep and
Metabolism
10:30am – 12:30pm
Chair:
Frank Scheer, PhD
Faculty:
Marta Garaulet, PhD; Christopher Morris, PhD;
Esra Tasali, MD; and Kenneth Wright, Jr., PhD
Psychologist Level of Content:
Intermediate
Objectives:
1. Describe the impact of the circadian system,
physiological sleep and timing of food intake
on glucose metabolism, caloric intake, energy
expenditure and body weight regulation;
25
